Roy S. Herbst

Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center (YCC) and Yale School of Medicine. Dr. Herbst is also a fellow of the American Society of Clinical Oncology (ASCO) and the American College of Physicians, an elected member of the Association of American Physicians, and an elected member of the boards of directors for both AACR and the IASLC. Dr. Herbst is a pioneer of personalized medicine and immunotherapy to identify biomarkers and bring novel targeted treatments to patients, serving as principal investigator for trials leading to approval of several therapies revolutionizing the field and greatly enhancing patients’ lives. He has more than 300 publications to his name, and his work published in Nature was awarded Clinical Research Forum’s 2015 Herbert Pardes Clinical Research Excellence Award.